Wyndham Hotel Group Signs Deal for First Wyndham Resort in

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Wyndham Hotel Group Signs Deal for First Wyndham Resort in Costa Rica

GUANACASTE, COSTA RICA --(Marketwired - September 12, 2014) - Wyndham Hotel Group, the world's largest hotel company with approximately 7,540 hotels and part of Wyndham Worldwide Corporation ( NYSE : WYN ), today announced the signing of a franchise agreement for the first resort in Costa Rica to fly the upscale Wyndham Hotels and Resorts® brand flag, the Wyndham Papagayo Yu Resort in Guanacaste.

The 151-room property, owned by ASECCSS, is currently under development in one of the most popular vacation destinations in Latin America and is scheduled to open by the end of 2015. It will be a mixed-use resort affiliated with RCI, the worldwide leader in vacation exchange and part of Wyndham Hotel Group's sister company, Wyndham Exchange & Rentals.

Wyndham Hotel Group has expanded its Wyndham Hotels and Resorts brand in key resort markets throughout Central America in recent years as part of its larger strategy to expand the flagship brand's presence throughout Latin America. Since 2012, two Wyndham®-branded resorts in Panama have joined the portfolio and the first Wyndham resort in Nicaragua is scheduled to open in 2015. Elsewhere in Latin America, the first Wyndham hotels opened in Ecuador, Colombia and Peru last year.

Upon opening, Wyndham Papagayo Yu Resort will join two city-center Wyndham properties currently open in Costa Rica, Wyndham Garden San Jose Escazú and Wyndham San Jose Herradura.

"A key factor in our growth in Latin America and the Caribbean is further expanding the Wyndham brand's resort offerings in key leisure destinations," said Paulo Pena, president and managing director of Latin America for Wyndham Hotel Group. "Guanacaste's popularity among international travelers as a top vacation spot makes it an essential location for us to be present. We're thrilled to work with ASECCSS to break ground on Wyndham Papagayo Yu Resort, which will be a beautiful retreat for travelers and a shining example of the resort experience the Wyndham brand offers."

Wyndham Papagayo Yu Resort will be situated along Playa Panamá in Guanacaste, an area known for pristine beaches, world-class surfing and lively culture. The resort is conveniently located just 12.5 miles from Liberia International Airport and will give guests immediate access to the region's attractions, including Arenal Volcano, Hanging Bridges and numerous national parks, as well as countless sporting and adventure activities, tours and wildlife.

Resort services and amenities will include two on-site restaurants, shops, a pool, sports courts, a gym and a spa. All guest accommodations, comprised of standard and junior suites, will offer ocean views.

Wyndham Hotel Group is focused on expanding its brands' footprints in Latin America. As of June 30, 2014, the Hotel Group had 127 hotels open in Latin America and the Caribbean, 14 of which operate in four Central American countries under the Howard Johnson® (one hotel), Ramada® (two hotels), TRYP by Wyndham® (four hotels) and Wyndham Hotels and Resorts (seven hotels) brand flags.

Guests staying at the hotel who are members of Wyndham Rewards®, the free-to-join guest loyalty program of Wyndham Hotels and Resorts and parent company Wyndham Hotel Group, will be able to earn valuable points during their stay. Points may be redeemed for a wide variety of reward options including free hotel stays, air travel, gift cards for leading retailers and restaurants and more. Information is available at www.wyndhamrewards.com .

About Wyndham Hotels and Resorts Wyndham Hotels and Resorts, LLC, a subsidiary of Wyndham Worldwide Corporation ( NYSE : WYN ), offers upscale hotel and resort accommodations at more than 170 properties throughout the United States, Canada, Mexico, Central and South America, the Caribbean, Europe, the Middle East and China. All Wyndham® hotels are either franchised by Wyndham Hotels and Resorts, LLC or one of its affiliates, or managed by Wyndham Hotel Management, Inc. or one of its affiliates. Additional information and reservations for all Wyndham hotels are available by visiting www.wyndham.com .

About Wyndham Hotel Group Wyndham Hotel Group, part of Wyndham Worldwide Corporation ( NYSE : WYN ), is the world's largest and most diverse hotel company with approximately 7,540 hotels and 650,200 rooms in 71 countries under the hotel brands: Wyndham Hotels and Resorts®, Ramada®, Days Inn®, Super 8®, Wingate by Wyndham®, Baymont Inn & Suites®, Microtel Inn & Suites by Wyndham®, Hawthorn Suites by Wyndham®, TRYP by Wyndham®, Howard Johnson®, Travelodge® and Knights Inn®. In addition, the company has a license agreement to franchise the Planet Hollywood Hotels brand and provide management services globally.

All hotels are independently owned and operated excluding certain hotels which are owned or managed by an affiliate of Wyndham Hotel Group.

Wyndham Rewards®, the guest loyalty program of Wyndham Hotel Group, is the world's largest lodging loyalty program as measured by number of participating hotels. It offers over 37 million members the opportunity to earn valuable points for qualified stays at more than 7,000 hotels in 50 countries. In addition to free stays, members may redeem their points for hundreds of reward options. For more information, visit www.wyndhamrewards.com .

Wyndham Hotel Group is based in Parsippany, New Jersey, U.S. Additional information is available at www.wyndhamworldwide.com . For more information about hotel franchising opportunities visit www.whgdevelopment.com . For Wyndham Hotel Group "@ a Glance," click here .

Image Available: http://www.marketwire.com/library/MwGo/2014/9...433242.jpg

CONTACT : Kathryn Zambito Wyndham Hotel Group 22 Sylvan Way Parsippany, NJ 07054 (973) 753-6590 kathryn.zambito@wyn.com  

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 363

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 229

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 380

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 308

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 218

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Orion Corporation's Manager Transactions Highlight Executive Moves

Updated Category News Views 133

Understanding Orion Corporation's Executive Transactions Orion Corporation, a prominent player in the global pharmaceutical industry, has recently disclosed significant transactions involving its management, shedding light on financial movements that reflect company growth and strategy. Key Details on Managerial Transactions Recently, Orion Corporation reported under the...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 150

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading
Investigating Claims for StubHub Investors: Your Options

Updated Category News Views 173

Investigation of Claims on Behalf of StubHub Investors Faruqi & Faruqi, LLP, a prominent name in national securities law, is currently looking into potential claims related to StubHub Holdings, Inc. (NYSE: STUB). This initiative aims to assist investors who might have faced losses due to the misleading statements made about the company's financial performance during its...

Continue Reading
Sarepta Therapeutics Faces Class Action Amid Safety Concerns

Updated Category News Views 256

Introduction to Sarepta Therapeutics Sarepta Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative therapies for rare diseases, particularly those associated with genetic factors. The company is well-known for its gene therapy treatments and aims to revolutionize treatment options for patients with Duchenne muscular dystrophy and similar...

Continue Reading